The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(20S)-21-(Bis(trifluoromethyl)hydroxymethyl)pregn-5-en-3beta,20-diol ID: ALA3819473
Cas Number: 102586-30-1
PubChem CID: 97290924
Max Phase: Preclinical
Molecular Formula: C24H34F6O3
Molecular Weight: 484.52
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@@H](O)CC(O)(C(F)(F)F)C(F)(F)F
Standard InChI: InChI=1S/C24H34F6O3/c1-20-9-7-14(31)11-13(20)3-4-15-16-5-6-18(21(16,2)10-8-17(15)20)19(32)12-22(33,23(25,26)27)24(28,29)30/h3,14-19,31-33H,4-12H2,1-2H3/t14-,15-,16-,17-,18+,19-,20-,21-/m0/s1
Standard InChI Key: OHKBOEWLASAFLW-FJWDNACWSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
8.5033 2.5246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1993 3.2675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1910 4.7682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1792 -0.4015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1792 -1.8432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9382 -2.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9565 0.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6790 -0.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6790 -1.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4197 -2.5550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8212 -1.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4380 0.3285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8030 -0.3650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8030 2.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4562 1.7885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0440 1.7885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0440 0.3467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5625 0.3285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5625 1.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3032 2.5367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6930 0.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2209 -2.4390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0413 2.9885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5993 3.2532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9034 2.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5927 4.4532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2059 2.0675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2265 5.3746 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1838 5.9682 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.1483 5.3621 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.5395 3.1300 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.5458 1.9302 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.5099 1.3246 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6715 -0.8608 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.4332 -0.6715 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2979 -0.6205 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3.3325 1.5372 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
4 7 1 0
5 6 1 0
6 9 1 0
8 7 1 0
8 9 1 0
8 12 1 0
9 10 2 0
10 11 1 0
11 13 1 0
12 13 1 0
12 15 1 0
13 17 1 0
16 14 1 0
14 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
8 21 1 1
5 22 1 1
16 23 1 1
20 24 1 0
24 25 1 0
24 26 1 1
25 2 1 0
2 27 1 0
3 28 1 0
3 29 1 0
3 30 1 0
1 31 1 0
1 32 1 0
1 33 1 0
13 34 1 1
12 35 1 6
17 36 1 6
20 37 1 6
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 484.52Molecular Weight (Monoisotopic): 484.2412AlogP: 5.53#Rotatable Bonds: 3Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.91CX Basic pKa: ┄CX LogP: 4.28CX LogD: 4.16Aromatic Rings: ┄Heavy Atoms: 33QED Weighted: 0.36Np Likeness Score: 1.83
References 1. Castelli R, Giacomini A, Anselmi M, Bozza N, Vacondio F, Rivara S, Matarazzo S, Presta M, Mor M, Ronca R.. (2016) Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors., 59 (10): [PMID:27138345 ] [10.1021/acs.jmedchem.5b02021 ] 2. Castelli R, Taranto S, Furiassi L, Bozza N, Marseglia G, Ferlenghi F, Rivara S, Retini M, Bedini A, Spadoni G, Matarazzo S, Ronca R, Presta M, Mor M, Giacomini A.. (2021) Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma., 221 [PMID:34004471 ] [10.1016/j.ejmech.2021.113529 ]